Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) announced it would be bought by Graft Polymer (UK) PLC with Graft acquiring all of the company’s shares in a deal valued at C$8.8 million. Graft is a UK-based biotechnology company listed on the London Stock Exchange under the symbol “GPL” and is currently focused on developing […]
The Journal of American Medical Association (JAMA) published a report this week noting the increase in diversions of the drug ketamine. The report was authored by Joseph J. Palamar, PhD, Caroline Rutherford, MS and Katherine M. Keyes, PhD. and they obtained data on undistributed pharmaceutical ketamine diversion from the DEA via a Freedom of Information Act request. Palamar […]
The Department of Veterans Affairs will fund a $1.5 million study of MDMA-assisted psychotherapy for veterans with PTSD and alcohol use disorder, marking its first foray into psychedelic research in over 50 years, officials announced Tuesday. The clinical trial, led by Brown and Yale researchers, begins enrolling participants in fiscal year 2025 at VA medical […]
Relmada also told investors that it didn’t think it had enough money to last a year from now. Relmada Therapeutics (Nasdaq: RLMD) provided a corporate update and announced preliminary and unaudited financial results for the third quarter ending Sept. 30. The company does not have revenue to report as of yet. Net loss for the […]
(This story first appeared at reMind, a psychedelics business platform. The reMind Psychedelics Business Forum is Dec. 3 at MJBizCon. Full information about the forum is available here.) New Jersey lawmakers are hoping to succeed with psychedelics policy reform in ways their counterparts in California and Connecticut have not – at least not so far. […]
Oregon, the first state to fully legalize psychedelics, will roll out therapy this year, with the rest of the country watching closely for cautionary tales and of course, success stories. Not to be outdone, NY and California have also pushed for similar proposals. Both proposals would relax laws around certain hallucinogens, including psilocybin, ibogaine and DMT, […]
Oregon, the first state to fully legalize psychedelics, will roll out therapy this year, with the rest of the country watching closely for cautionary tales and of course, success stories. Not to be outdone, NY and California have also pushed for similar proposals. Both proposals would relax laws around certain hallucinogens, including psilocybin, ibogaine and DMT, […]
